Constipation may resolve, or new digestive patterns may emerge If you experienced constipation on GLP-1 medication , it often resolves after stopping as gastric motility returns to normal
Clinical trials have demonstrated that GLP-1 receptor agonists produce substantial reductions in total body weight, with emerging evidence suggesting effects on visceral adipose tissuethe metabolically active fat stored around abdominal organs
This safety overview is not exhaustive
Sometimes, if something seems too good to be true, it may be too good to be true
Professor Moses Elisaf has received speaker honoraria, consulting fees, and research funding from AstraZeneca, Schering Plough, Merck, Pfizer, Solvay, Abbott, Boehringer Ingelheim, and Fournier, and has participated in clinical trials with AstraZeneca, Merck, Sanofi-Synthelabo, Solvay, Glaxo, Novartis, Pfizer, and Fournier
Look for strains specifically studied for constipation, such as Bifidobacterium lactis and Lactobacillus reuteri
,aspect=fit)
